Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q3 EPS of ($0.91), $0.21 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.